The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans

Neurotox Res. 2020 Oct;38(3):751-764. doi: 10.1007/s12640-020-00262-5. Epub 2020 Jul 29.

Abstract

In a previous study, we have shown that methylmercury (MeHg) exposure causes focal aggregation of intracellular transgenic mCherry protein in dendrites of cephalic (CEP) neurons in Caenorhabditis elegans (C. elegans). However, the underlying mechanism is unknown. We hypothesized that reduced cellular release of mCherry via extracellular vesicles by MeHg contributes to its accumulation and intracellular aggregation. Thus, we characterized vesicular structures in CEP dendrites, which were 1-3 μm in diameter and could readily bud off from the plasma membrane of the dendrites. Chronic treatment of C. elegans with MeHg (5 μM, 4-10 days) reduced the number of vesicles attached to CEP dendrites (attached vesicles) and vesicles unattached to CEP dendrites (unattached vesicles), as well as the presence of extracellular mCherry, supporting the hypothesis that release of mCherry by microvesicle formation is inhibited by MeHg. Leucine-rich repeat kinase 2 (LRRK2) has an important function in membrane biology. Further investigation showed that the effects of MeHg were modified by human LRRK2. In worms with the wild-type LRRK2, the vesicle numbers were significantly reduced by MeHg (0.5 and 5 μM). The effects of MeHg on the presence of extracellular mCherry and attached vesicles were modified by the human wild-type LRRK2. Independent of MeHg treatment, the G2019S mutant LRRK2 showed reduced number of unattached vesicles; however, the levels of extracellular mCherry were increased. Knockdown of C. elegans irk-1, the homolog of human LRRK2, reduced the number of attached vesicles, corroborating that LRRK2 plays an important role in the formation of microvesicles.

Keywords: CEP neuron; Leucine-rich repeat kinase 2; Methylmercury; Microvesicle.

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Caenorhabditis elegans / drug effects
  • Caenorhabditis elegans / metabolism
  • Cytoplasm / metabolism
  • Disease Models, Animal
  • Dopaminergic Neurons / drug effects*
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics*
  • Methylmercury Compounds / pharmacology*
  • Microvessels / drug effects*
  • Mutation / drug effects
  • Mutation / genetics
  • Protein Serine-Threonine Kinases / genetics

Substances

  • Methylmercury Compounds
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases